REQUEST A DEMO
Total
USD $0.00
Search more companies

Torhovyi Dim Novofarm-Biosyntez Tov (Ukraine)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Torhovyi Dim Novofarm-Biosyntez Tov Profile Updated: March 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Torhovyi Dim Novofarm-Biosyntez Tov is a company in Ukraine, with a head office in Kyiv. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on March 27, 2002. The total number of employees is currently 32 (2024). From the latest financial highlights, Torhovyi Dim Novofarm-Biosyntez Tov reported a net sales revenue increase of 21.41% in Q2C2026. During that time, Torhovyi Dim Novofarm-Biosyntez Tov’s total assets grew by 25.3%. In, 2026, the company’s net profit margin decreased by 0.19%.

Headquarters
6A, Of. 4, 5, Prov. Zadorozhnyi
Kyiv; Kiev; Postal Code: 03040

Contact Details: Purchase the Torhovyi Dim Novofarm-Biosyntez Tov report to view the information.

Website: http://novofarm.com.ua

Basic Information
Total Employees:
Purchase the Torhovyi Dim Novofarm-Biosyntez Tov report to view the information.
Registered Capital:
Purchase the Torhovyi Dim Novofarm-Biosyntez Tov report to view the information.
Financial Auditors:
Purchase the Torhovyi Dim Novofarm-Biosyntez Tov report to view the information.
Incorporation Date:
March 27, 2002
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Torhovyi Dim Novofarm-Biosyntez Tov report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
21.41%
Total Operating Revenue
18.42%
Net Profit/Loss for the Period
4.34%
Total Assets
25.3%
Total Equity
2.19%
Net Profit Margin
-0.19%
Return on Equity (ROE)
0.08%
Quick Ratio
-0.12%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?